BC Cancer Agency's GSC Installs 8 More SOLiDs for Cancer Genome Projects; Also Plans Illumina Expansion

The center will use its 10 SOLiD units initially primarily for whole-genome cancer sequencing of breast and ovarian tumors. Over the next 12 months, the GSC also plans to expand its Illumina sequencing capacity.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.